Toronto Dominion Bank
TLSIW icon

Toronto Dominion Bank’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Toronto Dominion Bank’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.46K Hold
5,170
– – ﹤0.01% 1959
2025
Q4 		$7.86K Hold
5,170
– – ﹤0.01% 1843
2025
Q3 		$8.48K Sell
5,170
-4,213
-45% -$7.66K ﹤0.01% 1771
2025
Q2 		$12.1K Buy
+9,383
New +$13.3K ﹤0.01% 1619

Other funds holding TLSIW

Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Toronto Dominion Bank's TLSIW Position: Q1 2026 in Review

Toronto Dominion Bank held its TriSalus Life Sciences Warrant (TLSIW) position steady in Q1 2026 at 5,170 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.

Toronto Dominion Bank first reported a position in TLSIW in Q2 2025 and has held it in 4 quarters since. The position peaked at $12.1K in Q2 2025. 7 funds tracked by Wall St. Rank hold TLSIW as of Q1 2026.

  • Toronto Dominion Bank held 5,170 shares of TriSalus Life Sciences Warrant worth $6.46K as of Q1 2026.
  • Toronto Dominion Bank left its TriSalus Life Sciences Warrant share count unchanged in Q1 2026.
  • TriSalus Life Sciences Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1959 holding.
  • Toronto Dominion Bank first reported a position in TriSalus Life Sciences Warrant in Q2 2025 and has held it in 4 quarters since.
  • Toronto Dominion Bank's TriSalus Life Sciences Warrant position peaked at $12.1K in Q2 2025.
  • 7 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.